Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 1, 2026

On Apr 1, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$66.63 for US$500K under a trading plan, leaving 422,830 shares. Filed Apr 1, 2026 (Form 4).

Sold
7,500 shares
Price
US$66.63
Value
US$500K
Holding after
422,830 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockSale7,500US$66.63422,830Direct

Source

View original at SEC

Related